Shaolong He
Taiyuan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Endoplasmic reticulum stress promotes leukemic plasmacytoid dendritic cell differentiation skewing and immune suppression in acute myeloid leukemia.
Journal: Leukemia
Published: March 30, 2026
Impact of frailty tools on outcomes in myeloma: MRP and simplified index predict survival but differ in infection risk stratification.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 09, 2026
Febrile neutropenia adversely affects chemomobilization outcomes in patients with multiple myeloma and increases risk for post-transplant infection in those with lymphoma: real-world multicenter data.
Journal: Blood science (Baltimore, Md.)
Published: July 01, 2025
Pomalidomide improves the effectiveness of CAR-T treatment in the relapsed and refractory multiple myeloma or B-cell leukemia/lymphoma with extramedullary disease.
Journal: Blood science (Baltimore, Md.)
Published: May 05, 2023
Peripheral Blood Smears Distinguish Infective Fever after CAR-T Therapy.
Journal: Frontiers in bioscience (Landmark edition)
Published: March 31, 2023
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era.
Journal: Experimental hematology & oncology
Published: March 14, 2023
Lack of surgical resection is associated with increased early mortality in hematological patients complicated with rhino-orbital-cerebral mucormycosis.
Journal: Annals of hematology
Published: March 06, 2023
Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
Journal: Critical reviews in oncology/hematology
Published: December 30, 2022
Eastern Cooperative Oncology Group, β2-microglobulin, hemoglobin, and lactate dehydrogenase can predict early grade ≥ 3 infection in patients with newly diagnosed multiple myeloma: A real-world multicenter study.
Journal: Frontiers in microbiology
Published: December 03, 2022
Carfilzomib inhibits the proliferation and apoptosis of multiple myeloma cells by inhibiting STAT1/COX-2/iNOS signaling pathway.
Journal: Translational cancer research
Published: August 04, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026